Search

Your search keyword '"Catherine Viguié"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Catherine Viguié" Remove constraint Author: "Catherine Viguié"
97 results on '"Catherine Viguié"'

Search Results

1. Lithium and endocrine disruption: A concern for human health?

2. Gestational exposure to bisphenol A induces region-specific changes in brain metabolomic fingerprints in sheep

3. Are BPA Substitutes as Obesogenic as BPA?

4. How to Differentiate General Toxicity-Related Endocrine Effects from Endocrine Disruption: Systematic Review of Carbon Disulfide Data

5. The highly prolific phenotype of Lacaune sheep is associated with an ectopic expression of the B4GALNT2 gene within the ovary.

7. Hormonal profile changes induced by pesticide mixture exposure in female rats revealed by hair analysis

8. Regulatory and academic studies to derive reference values for human health: The case of bisphenol S

9. Absence d’efficacité de la quinacrine dans le traitement des maladies à prions : possible explication à caractère pharmacologique

10. Measurement of hair thyroid and steroid hormone concentrations in the rat evidence endocrine disrupting potential of a low dose mixture of polycyclic aromatic hydrocarbons

11. Quantitative method for conjugated metabolites of bisphenol A and bisphenol S determination in food of animal origin by Ultra High Performance Liquid Chromatography–Tandem Mass Spectrometry

12. The trouble with endocrine disruptors

13. Toward a better understanding of the effects of endocrine disrupting compounds on health: Human-relevant case studies from sheep models

14. Transcriptomic modifications of the thyroid gland upon exposure to phytosanitary-grade fipronil: Evidence for the activation of compensatory pathways

15. Développement d'une approche intégrative modélisatrice pour évaluer l'exposition interne foetale humaine à un contaminant, appliquée au bisphénol A au titre de molécule modèle

16. Developpement d'une approche intégrative pour évaluer l'exposition interne foetale humaine au bisphénol S

17. Oral Systemic Bioavailability of Bisphenol A and Bisphenol S in Pigs

18. Regulatory identification of BPA as an endocrine disruptor : Context and methodology

19. Bisphenol A glucuronide deconjugation is a determining factor of fetal exposure to bisphenol A

20. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta

21. Maternal parity affects placental development, growth and metabolism of foals until 1 year and a half

22. Evidence-based adverse outcome pathway approach for the identification of BPA as en endocrine disruptor in relation to its effect on the estrous cycle

23. Bisphenol S, used as bisphenol A alternative, accumulates in the fetal compartment throughout gestation

24. Doit-on remplacer le bisphénol A par le bisphénol S? Contribution de la SPE-UPLC-MS/MS pour évaluer les déterminants de l'exposition fӕtale au BPS sur un modèle ovin

25. Disposition du Bisphénol S et de son principal métabolite dans l’unité materno-foeto-placentaire

26. Development of an on-line solid phase extraction ultra performance liquid chromatography technique coupled to tandem mass spectrometry for quantification of bisphenol S and bisphenol S glucuronide: applicability to toxicokinetic investigations

27. Evidence for bisphenol A-induced disruption of maternal thyroid homeostasis in the pregnant ewe at low level representative of human exposure

28. Disposition of fipronil in rats

29. Exploring the interplay between the cental nervous and endocrine systems for identifying biomarkers of effect of developmental exposure to endocrine disruptors: a sheep point of view

30. Characterization of the contribution of buccal absorption to internal exposure to bisphenol A through the diet

31. CYP450-Dependent Biotransformation of the Insecticide Fipronil into Fipronil Sulfone Can Mediate Fipronil-Induced Thyroid Disruption in Rats

32. Competitive binding to plasma thyroid hormone transport proteins and thyroid disruption by phenylbutazone used as a probe

33. Quantification of fipronil and its metabolite fipronil sulfone in rat plasma over a wide range of concentrations by LC/UV/MS

34. Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors

35. Conjugation and deconjugation reactions within the fetoplacental compartment in a sheep model: a key factor determining bisphenol A fetal exposure

36. Allometric scaling for predicting human clearance of bisphenol A

37. Comment on 'In vitro effects of bisphenol A β-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes'

38. 5.9. Les Perturbateurs Endocriniens

39. A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie

40. Bidirectional placental transfer of bisphenol A and its main metabolite, bisphenol A-glucuronide, in the isolated perfused human placenta

41. Impacts agronomiques, environnementaux, socio-économiques. Rapport

42. Endotoxin Inhibits Pituitary Responsiveness to Gonadotropin-Releasing Hormone1

43. Importance of Photoperiodic Signal Quality to Entrainment of the Circannual Reproductive Rhythm of the Ewe1

44. Prostaglandins Mediate the Endotoxin-Induced Suppression of Pulsatile Gonadotropin-Releasing Hormone and Luteinizing Hormone Secretion in the Ewe*

45. Endocrine Alterations That Underlie Endotoxin-Induced Disruption of the Follicular Phase in Ewes1

46. Endotoxin Disrupts the Estradiol-Induced Luteinizing Hormone Surge: Interference with Estradiol Signal Reading, Not Surge Release*

47. Thyroid Hormones Act Primarily within the Brain to Promote the Seasonal Inhibition of Luteinizing Hormone Secretion in the Ewe*

48. Median Eminence Dopaminergic Activation Is Critical for the Early Long-Day Inhibition of Luteinizing Hormone Secretion in the Ewe**Presented, in preliminary form, at the Congress 'Bioclock’s 97: the photic system and time measurement in Vertebrates,' Poitiers, France, July 9–11, 1997

49. Systemic Challenge with Endotoxin Stimulates Corticotropin-Releasing Hormone and Arginine Vasopressin Secretion into Hypophyseal Portal Blood: Coincidence with Gonadotropin-Releasing Hormone Suppression**Preliminary reports have appeared in Biol Reprod [Suppl 1] 54:93, 1996, and the 1997 Program and Abstracts of the 79th Annual Meeting of The Endocrine Society, Minneapolis, Minnesota, p 99. This work was supported by NIH Grants MH-11653 and HD-18337; the Sheep Research, Standards and Reagents, Data Analysis, and Administrative Core Facilities of the P30 Center for the Study of Reproduction (NIH Grant HD-18258); and the Office of the Vice President for Research at the University of Michigan

50. Bidirectional placental transfer of BPA and its metabolite in the perfused human placental cotyledon model

Catalog

Books, media, physical & digital resources